Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.2%

1 terminated out of 46 trials

Success Rate

91.7%

+5.1% vs benchmark

Late-Stage Pipeline

9%

4 trials in Phase 3/4

Results Transparency

0%

0 of 11 completed with results

Key Signals

92% success

Data Visualizations

Phase Distribution

27Total
Not Applicable (16)
P 2 (7)
P 3 (2)
P 4 (2)

Trial Status

Unknown19
Completed11
Recruiting6
Active Not Recruiting4
Withdrawn3
Not Yet Recruiting1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (46)

Showing 20 of 20 trials
NCT07581236Not ApplicableCompleted

A Single-center, Single-arm Clinical Study Evaluating the Short-term Efficacy of Inflatable Mediastinoscopic-assisted Transhiatal Laparoscopic Esophagectomy for the Radical Resection of Thoracic Esophageal Cancer

NCT07542912Not ApplicableNot Yet Recruiting

Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma

NCT07521397Completed

Pooled Analysis of Patients With Early-stage Breast Cancer Treated With Adjuvant Dose-dense Sequential Chemotherapy: a Hellenic Cooperative Oncology Group (HeCOG) Study.

NCT05024175Recruiting

Long-term Follow-up of Subjects Treated With CAR T Cells

NCT07258043Recruiting

Efficacy of Dose-Adjusted Regimen on Survival in Frail Adults With Acute Lymphoblastic Leukemia

NCT04204798Not ApplicableActive Not Recruiting

Dexmedetomidine and Outcomes of Elderly Admitted to ICU After Surgery

NCT04025840Phase 4Active Not Recruiting

Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery

NCT04209218Not ApplicableRecruiting

Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery

NCT06868095Enrolling By Invitation

Multi-Center Study Protocol: Impact of Sarcopenia in Early-Onset Colorectal Cancer.

NCT04947020Completed

DataBase for Analysis of Rectal Cancer Oncological Results

NCT06527001Active Not Recruiting

Mesenteric Lymph Node Metastasis and Nutritional Status After Bowel Resection for Ovarian Cancer

NCT06462742RecruitingPrimary

Microwave Ablation Versus Liver Resection for Intrahepatic Cholangiocarcinoma

NCT05477797Not ApplicableRecruiting

Id and Rd Maintenance Regimens After Induction of Remission in Multiple Myeloma.

NCT06215495Not ApplicableRecruiting

A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial

NCT04245644Active Not Recruiting

Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study

NCT05796700Not ApplicableCompletedPrimary

Microwave Ablation Versus Laparoscopic Hepatectomy for 3-5cm Hepatocellular Carcinoma

NCT03892577Unknown

Real-world Study for Patients With Advanced Hepatobiliary Tumors

NCT05218629Phase 2UnknownPrimary

Anlotinib Plus PD-1 Inhibitor as 2nd-line Threapy in Patients With Metastatic Pancreatic Cancer

NCT03726021Phase 2CompletedPrimary

Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer

NCT05656222Not ApplicableWithdrawn

Irinotecan and Anlotinib for Epithelioid Sarcoma

Scroll to load more

Research Network

Activity Timeline